{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HER2-positive breast cancer", "actein", "brain-metastasis", "human epidermal growth factor receptor 2 (HER2)", "metastasis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "32547952", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "27"}], "Language": ["eng"], "ELocationID": ["854", "10.3389/fonc.2020.00854"], "Journal": {"ISSN": "2234-943X", "JournalIssue": {"Volume": "10", "PubDate": {"Year": "2020"}}, "Title": "Frontiers in oncology", "ISOAbbreviation": "Front Oncol"}, "ArticleTitle": "Actein Inhibits Tumor Growth and Metastasis in HER2-Positive Breast Tumor Bearing Mice via Suppressing AKT/mTOR and Ras/Raf/MAPK Signaling Pathways.", "Pagination": {"StartPage": "854", "MedlinePgn": "854"}, "Abstract": {"AbstractText": ["HER2-positive breast cancer accounts for 15-20% in breast cancer and 50% of the metastatic HER2-positive breast cancer patients died of central nervous system progression. The present study investigated the effects of actein (a natural cycloartane triterpene) on cells adhesion, migration, proliferation and matrix degradation, and its underlying mechanism in HER2-positive breast cancer cells. The <i>in vivo</i> effect of actein on tumor growth and metastasis in MDA-MB-361 tumor-bearing mice as well as the anti-brain metastasis in tail vein injection mice model were also investigated. Our results showed that actein inhibited HER2-positive breast cancer cells viability, proliferation and migration. Actein also induced MDA-MB-361 cells G1 phase arrest and inhibited the expressions of cyclins and cyclin-dependent kinases. For intracellular mechanisms, actein inhibited the expressions of molecules in AKT/mTOR and Ras/Raf/MAPK signaling pathways. Furthermore, actein (15 mg/kg) was shown to exhibit anti-tumor and anti-metastatic activities in MDA-MB-361 breast tumor-bearing mice, and reduced brain metastasis in tail vein injection mice model. All these findings strongly suggested that actein is a potential anti-metastatic agent for HER2-positive breast cancer."], "CopyrightInformation": "Copyright \u00a9 2020 Wu, Yue, Dong, Lam, Wong, Qiu and Lau."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Wu", "ForeName": "Xiao-Xiao", "Initials": "XX"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Yue", "ForeName": "Grace Gar-Lee", "Initials": "GG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China."}], "LastName": "Dong", "ForeName": "Jin-Run", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Medicine, Macau University of Science and Technology, Macau, China."}], "LastName": "Lam", "ForeName": "Christopher Wai-Kei", "Initials": "CW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Wong", "ForeName": "Chun-Kwok", "Initials": "CK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China."}], "LastName": "Qiu", "ForeName": "Ming-Hua", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Lau", "ForeName": "Clara Bik-San", "Initials": "CB"}], "DataBankList": [{"DataBankName": "figshare", "AccessionNumberList": ["10.6084/m9.figshare.12212642"]}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Oncol", "NlmUniqueID": "101568867", "ISSNLinking": "2234-943X"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Loibl S, Gianni L. HER2-positive breast cancer. Lancet. (2017) 389:2415\u201329. 10.1016/S0140-6736(16)32417-5", "ArticleIdList": ["10.1016/S0140-6736(16)32417-5", "27939064"]}, {"Citation": "Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. . Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. (2013) 31:3997\u20134013. 10.1200/JCO.2013.50.9984", "ArticleIdList": ["10.1200/JCO.2013.50.9984", "24101045"]}, {"Citation": "Mustacchi G, Biganzoli L, Pronzato P, Montemurro F, Dambrosio M, Minelli M, et al. . HER2-positive metastatic breast cancer: a changing scenario. Crit Rev Oncol Hematol. (2015) 95:78\u201387. 10.1016/j.critrevonc.2015.02.002", "ArticleIdList": ["10.1016/j.critrevonc.2015.02.002", "25748080"]}, {"Citation": "Chen W, Hoffmann AD, Liu H, Liu X. Organotropism: new insights into molecular mechanisms of breast cancer metastasis. NPJ Precis Oncol. (2018) 2:4. 10.1038/s41698-018-0047-0", "ArticleIdList": ["10.1038/s41698-018-0047-0", "PMC5871901", "29872722"]}, {"Citation": "Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, et al. . Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol. (2006) 17:935\u201344. 10.1093/annonc/mdl064", "ArticleIdList": ["10.1093/annonc/mdl064", "16603601"]}, {"Citation": "Kirsch DG, Loeffler JS. Brain metastases in patients with breast cancer: new horizons. Clin Breast Cancer. (2005) 6:115\u201324. 10.3816/CBC.2005.n.013", "ArticleIdList": ["10.3816/CBC.2005.n.013", "16001989"]}, {"Citation": "Honda Y, Aruga T, Yamashita T, Miyamoto H, Horiguchi K, Kitagawa D, et al. . Prolonged survival after diagnosis of brain metastasis from breast cancer: contributing factors and treatment implications. Jpn J Clin Oncol. (2015) 45:713\u20138. 10.1093/jjco/hyv067", "ArticleIdList": ["10.1093/jjco/hyv067", "25981620"]}, {"Citation": "Keating GM. Pertuzumab: in the first-line treatment of HER2-positive metastatic breast cancer. Drugs. (2012) 72:353\u201360. 10.2165/11209000-000000000-00000", "ArticleIdList": ["10.2165/11209000-000000000-00000", "22316351"]}, {"Citation": "Dawood S, Broglio K, Esteva FJ, Ibrahim NK, Kau SW, Islam R, et al. . Defining prognosis for women with breast cancer and CNS metastases by HER2 status. Ann Oncol. (2008) 19:1242\u20138. 10.1093/annonc/mdn036", "ArticleIdList": ["10.1093/annonc/mdn036", "18334512"]}, {"Citation": "Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, et al. . Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma. Cancer. (2003) 97:2972\u20137. 10.1002/cncr.11436", "ArticleIdList": ["10.1002/cncr.11436", "12784331"]}, {"Citation": "Milani A, Montemurro F, Gioeni L, Aglietta M, Valabrega G. Role of trastuzumab in the management of HER2-positive metastatic breast cancer. Breast Cancer (Dove Med Press). (2010) 2:93\u2013109. 10.2147/BCTT.S6070", "ArticleIdList": ["10.2147/BCTT.S6070", "PMC3846373", "24367170"]}, {"Citation": "Mehta AI, Brufsky AM, Sampson JH. Therapeutic approaches for HER2-positive brain metastases: circumventing the blood-brain barrier. Cancer Treat Rev. (2013) 39:261\u20139. 10.1016/j.ctrv.2012.05.006", "ArticleIdList": ["10.1016/j.ctrv.2012.05.006", "PMC4432469", "22727691"]}, {"Citation": "Krishnan M, Krishnamurthy J, Shonka N. Targeting the sanctuary site: options when breast cancer metastasizes to the brain. Oncology. (Williston Park) 33:683730.", "ArticleIdList": ["31469897"]}, {"Citation": "D'Amato V, Raimondo L, Formisano L, Giuliano M, De Placido S, Rosa R, et al. . Mechanisms of lapatinib resistance in HER2-driven breast cancer. Cancer Treat Rev. (2015) 41:877\u201383. 10.1016/j.ctrv.2015.08.001", "ArticleIdList": ["10.1016/j.ctrv.2015.08.001", "26276735"]}, {"Citation": "Taskar KS, Rudraraju V, Mittapalli RK, Samala R, Thorsheim HR, Lockman J, et al. . Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. Pharm Res. (2012) 29:770\u201381. 10.1007/s11095-011-0601-8", "ArticleIdList": ["10.1007/s11095-011-0601-8", "PMC3489161", "22011930"]}, {"Citation": "Larsen PB, Kumler I, Nielsen DL. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer. Cancer Treat Rev. (2013) 39:720\u20137. 10.1016/j.ctrv.2013.01.006", "ArticleIdList": ["10.1016/j.ctrv.2013.01.006", "23481218"]}, {"Citation": "Trendowski M. Recent advances in the development of antineoplastic agents derived from natural products. Drugs. (2015) 75:1993\u20132016. 10.1007/s40265-015-0489-4", "ArticleIdList": ["10.1007/s40265-015-0489-4", "PMC4642600", "26501980"]}, {"Citation": "Ji L, Zhong B, Jiang X, Mao F, Liu G, Song B, et al. . Actein induces autophagy and apoptosis in human bladder cancer by potentiating ROS/JNK and inhibiting AKT pathways. Oncotarget. (2017) 8:112498\u2013515. 10.18632/oncotarget.22274", "ArticleIdList": ["10.18632/oncotarget.22274", "PMC5762528", "29348843"]}, {"Citation": "Wang MS, Chen L, Xiong YQ, Xu J, Wang JP, Meng ZL. Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner. Int J Nanomedicine. (2017) 12:7627\u201351. 10.2147/IJN.S127549", "ArticleIdList": ["10.2147/IJN.S127549", "PMC5655152", "29089760"]}, {"Citation": "Xi R, Wang LJ. Actein ameliorates hepatobiliary cancer through stemness and p53 signaling regulation. Biomed Pharmacother. (2017) 88:242\u201351. 10.1016/j.biopha.2017.01.038", "ArticleIdList": ["10.1016/j.biopha.2017.01.038", "28110190"]}, {"Citation": "Zhang Y, Lian J, Wang X. Actein inhibits cell proliferation and migration and promotes cell apoptosis in human non-small cell lung cancer cells. Oncol Lett. (2018) 15:3155\u201360. 10.3892/ol.2017.7668", "ArticleIdList": ["10.3892/ol.2017.7668", "PMC5778823", "29435050"]}, {"Citation": "Einbond LS, Su T, Wu HA, Friedman R, Wang X, Ramirez A, et al. . The growth inhibitory effect of actein on human breast cancer cells is associated with activation of stress response pathways. Int J Cancer. (2007) 121:2073\u201383. 10.1002/ijc.22897", "ArticleIdList": ["10.1002/ijc.22897", "17621630"]}, {"Citation": "Einbond LS, Shimizu M, Ma H, Wu HA, Goldsberry S, Sicular S, et al. . Actein inhibits the Na+-K+-ATPase and enhances the growth inhibitory effect of digitoxin on human breast cancer cells. Biochem Biophys Res Commun. (2008) 375:608\u201313. 10.1016/j.bbrc.2008.08.054", "ArticleIdList": ["10.1016/j.bbrc.2008.08.054", "18755149"]}, {"Citation": "Einbond LS, Soffritti M, Esposti DD, Wu HA, Balick M, Ma H, et al. . A transcriptomic analysis of black cohosh: actein alters cholesterol biosynthesis pathways and synergizes with simvastatin. Food Chem Toxicol. (2018) 120:356\u201366. 10.1016/j.fct.2018.06.064", "ArticleIdList": ["10.1016/j.fct.2018.06.064", "29969672"]}, {"Citation": "Chen Z, Wu J, Guo Q. Actein inhibits cell proliferation and migration in human osteosarcoma. Med Sci Monit. (2016) 22:1609\u201316. 10.12659/msm.898483", "ArticleIdList": ["10.12659/msm.898483", "PMC4918520", "27173526"]}, {"Citation": "Yue GG, Xie S, Lee JK, Kwok HF, Gao S, Nian Y, et al. . New potential beneficial effects of actein, a triterpene glycoside isolated from Cimicifuga species, in breast cancer treatment. Sci Rep. (2016) 6:35263. 10.1038/srep35263", "ArticleIdList": ["10.1038/srep35263", "PMC5059658", "27731376"]}, {"Citation": "Wu XX, Yue GG, Dong JR, Lam CW, Wong CK, Qiu MH, et al. . Actein inhibits the proliferation and adhesion of human breast cancer cells and suppresses migration in vivo. Front Pharmacol. (2018) 9:1466. 10.3389/fphar.2018.01466", "ArticleIdList": ["10.3389/fphar.2018.01466", "PMC6299023", "30618758"]}, {"Citation": "Leung HW, Zhao SM, Yue GG, Lee JK, Fung KP, Leung PC, et al. . RA-XII inhibits tumour growth and metastasis in breast tumour-bearing mice via reducing cell adhesion and invasion and promoting matrix degradation. Sci Rep. (2015) 5:16985. 10.1038/srep16985", "ArticleIdList": ["10.1038/srep16985", "PMC4655310", "26592552"]}, {"Citation": "Li L, Yue GG, Lau CB, Sun H, Fung KP, Leung PC, et al. . Eriocalyxin B induces apoptosis and cell cycle arrest in pancreatic adenocarcinoma cells through caspase- and p53-dependent pathways. Toxicol Appl Pharmacol. (2012) 262:80\u201390. 10.1016/j.taap.2012.04.021", "ArticleIdList": ["10.1016/j.taap.2012.04.021", "22561874"]}, {"Citation": "Chen HJ, Liu J. Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant. Biomed Pharmacother. (2018) 97:1386\u201396. 10.1016/j.biopha.2017.09.093", "ArticleIdList": ["10.1016/j.biopha.2017.09.093", "29156528"]}, {"Citation": "Zhou WD, Wang X, Sun XZ, Hu J, Zhang RR, Hong Z. Actein induces apoptosis in leukemia cells through suppressing RhoA/ROCK1 signaling pathway. Int J Oncol. (2017) 51:1831\u201341. 10.3892/ijo.2017.4150", "ArticleIdList": ["10.3892/ijo.2017.4150", "29039493"]}, {"Citation": "Lehmann T, Solimando DA, Jr., Waddell JA. Paclitaxel and trastuzumab for breast cancer. Hosp Pharm. (2014) 49:338\u201344. 10.1310/hpj4904-338", "ArticleIdList": ["10.1310/hpj4904-338", "PMC4062745", "24958939"]}, {"Citation": "Lewis Phillips GD, Li G, Dugger DL, Crocker LM, Parsons KL, Mai E, et al. . Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. Cancer Res. (2008) 68:9280\u201390. 10.1158/0008-5472.CAN-08-1776", "ArticleIdList": ["10.1158/0008-5472.CAN-08-1776", "19010901"]}, {"Citation": "Daphu I, Sundstrom T, Horn S, Huszthy PC, Niclou SP, Sakariassen PO, et al. . In vivo animal models for studying brain metastasis: value and limitations. Clin Exp Metastasis. (2013) 30:695\u2013710. 10.1007/s10585-013-9566-9", "ArticleIdList": ["10.1007/s10585-013-9566-9", "23322381"]}, {"Citation": "Luo KW, Yue GG, Ko CH, Lee JK, Gao S, Li LF, et al. . In vivo and in vitro anti-tumor and anti-metastasis effects of Coriolus versicolor aqueous extract on mouse mammary 4T1 carcinoma. Phytomedicine. (2014) 21:1078\u201387. 10.1016/j.phymed.2014.04.020", "ArticleIdList": ["10.1016/j.phymed.2014.04.020", "24856767"]}, {"Citation": "Yue GG, Lee JK, Kwok HF, Cheng L, Wong EC, Jiang L, et al. . Novel PI3K/AKT targeting anti-angiogenic activities of 4-vinylphenol, a new therapeutic potential of a well-known styrene metabolite. Sci Rep. (2015) 5:11149. 10.1038/srep11149", "ArticleIdList": ["10.1038/srep11149", "PMC4459151", "26053458"]}, {"Citation": "Pu T, Xiong L, Liu Q, Zhang M, Cai Q, Liu H, et al. . Delineation of retroperitoneal metastatic lymph nodes in ovarian cancer with near-infrared fluorescence imaging. Oncol Lett. (2017) 14:2869\u201377. 10.3892/ol.2017.6521", "ArticleIdList": ["10.3892/ol.2017.6521", "PMC5588176", "28928826"]}, {"Citation": "Becker M, Nitsche A, Neumann C, Aumann J, Junghahn I, Fichtner I. Sensitive PCR method for the detection and real-time quantification of human cells in xenotransplantation systems. Br J Cancer. (2002) 87:1328\u201335. 10.1038/sj.bjc.6600573", "ArticleIdList": ["10.1038/sj.bjc.6600573", "PMC2408903", "12439725"]}, {"Citation": "Sirkisoon SR, Carpenter RL, Rimkus T, Miller L, Metheny-Barlow L, Lo HW. EGFR and HER2 signaling in breast cancer brain metastasis. Front Biosci (Elite Ed). (2016) 8:245\u201363. 10.2741/e765", "ArticleIdList": ["10.2741/e765", "PMC4809353", "26709660"]}, {"Citation": "Weigelt B, Peterse JL, van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. (2005) 5:591\u2013602. 10.1038/nrc1670", "ArticleIdList": ["10.1038/nrc1670", "16056258"]}, {"Citation": "Jonkers J, Derksen PW. Modeling metastatic breast cancer in mice. J Mammary Gland Biol Neoplasia. (2007) 12:191\u2013203. 10.1007/s10911-007-9050-8", "ArticleIdList": ["10.1007/s10911-007-9050-8", "17587153"]}, {"Citation": "Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. (2011) 11:411\u201325. 10.1038/nrc3055", "ArticleIdList": ["10.1038/nrc3055", "PMC3666847", "21593787"]}, {"Citation": "Lin NU, Gaspar LE, Soffietti R. Breast cancer in the central nervous system: multidisciplinary considerations and management. Am Soc Clin Oncol Educ Book. (2017) 37:45\u201356. 10.14694/EDBK_17533810.1200/EDBK_175338", "ArticleIdList": ["10.14694/EDBK_17533810.1200/EDBK_175338", "28561683"]}, {"Citation": "Diermeier S, Horvath G, Knuechel-Clarke R, Hofstaedter F, Szollosi J, Brockhoff G. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res. (2005) 304:604\u201319. 10.1016/j.yexcr.2004.12.008", "ArticleIdList": ["10.1016/j.yexcr.2004.12.008", "15748904"]}, {"Citation": "Gupta SC, Kim JH, Prasad S, Aggarwal BB. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. (2010) 29:405\u201334. 10.1007/s10555-010-9235-2", "ArticleIdList": ["10.1007/s10555-010-9235-2", "PMC2996866", "20737283"]}, {"Citation": "Hanai J, Dhanabal M, Karumanchi SA, Albanese C, Waterman M, Chan B, et al. . Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem. (2002) 277:16464\u20139. 10.1074/jbc.M112274200", "ArticleIdList": ["10.1074/jbc.M112274200", "11815623"]}, {"Citation": "Zhou A, Huntington JA, Pannu NS, Carrell RW, Read RJ. How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. Nat Struct Biol. (2003) 10:541\u20134. 10.1038/nsb943", "ArticleIdList": ["10.1038/nsb943", "12808446"]}, {"Citation": "Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. (2001) 17:463\u2013516. 10.1146/annurev.cellbio.17.1.463", "ArticleIdList": ["10.1146/annurev.cellbio.17.1.463", "PMC2792593", "11687497"]}, {"Citation": "Andreasen PA, Kjoller L, Christensen L, Duffy MJ. The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer. (1997) 72:1\u201322. 10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z", "ArticleIdList": ["10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z", "9212216"]}, {"Citation": "Deryugina EI, Quigley JP. Cell surface remodeling by plasmin: a new function for an old enzyme. J Biomed Biotechnol. (2012) 2012:564259. 10.1155/2012/564259", "ArticleIdList": ["10.1155/2012/564259", "PMC3477900", "23097597"]}, {"Citation": "Adamczyk A, Grela-Wojewoda A, Domagala-Haduch M, Ambicka A, Harazin-Lechowska A, Janecka A, et al. . Proteins involved in HER2 signalling pathway, their relations and influence on metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting. J Cancer. (2017) 8:131\u20139. 10.7150/jca.16239", "ArticleIdList": ["10.7150/jca.16239", "PMC5264049", "28123607"]}, {"Citation": "Steelman LS, Chappell WH, Abrams SL, Kempf RC, Long J, Laidler P, et al. . Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY). (2011) 3:192\u2013222. 10.18632/aging.100296", "ArticleIdList": ["10.18632/aging.100296", "PMC3091517", "21422497"]}, {"Citation": "Asati V, Mahapatra DK, Bharti SK. PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: structural and pharmacological perspectives. Eur J Med Chem. (2016) 109:314\u201341. 10.1016/j.ejmech.2016.01.012", "ArticleIdList": ["10.1016/j.ejmech.2016.01.012", "26807863"]}, {"Citation": "Kabraji S, Ni J, Lin NU, Xie S, Winer EP, Zhao JJ. Drug resistance in HER2-positive breast cancer brain metastases: blame the barrier or the brain? Clin Cancer Res. (2018) 24:1795\u2013804. 10.1158/1078-0432.CCR-17-3351", "ArticleIdList": ["10.1158/1078-0432.CCR-17-3351", "PMC5899637", "29437794"]}, {"Citation": "Turner PV, Brabb T, Pekow C, Vasbinder MA. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. (2011) 50:600\u201313.", "ArticleIdList": ["PMC3189662", "22330705"]}, {"Citation": "Eichler AF, Chung E, Kodack DP, Loeffler JS, Fukumura D, Jain RK. The biology of brain metastases-translation to new therapies. Nat Rev Clin Oncol. (2011) 8:344\u201356. 10.1038/nrclinonc.2011.58", "ArticleIdList": ["10.1038/nrclinonc.2011.58", "PMC3259742", "21487419"]}, {"Citation": "Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell. (2011) 147:275\u201392. 10.1016/j.cell.2011.09.024", "ArticleIdList": ["10.1016/j.cell.2011.09.024", "PMC3261217", "22000009"]}, {"Citation": "Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, et al. . Brain metastases: pathobiology and emerging targeted therapies. Acta Neuropathol. (2012) 123:205\u201322. 10.1007/s00401-011-0933-9", "ArticleIdList": ["10.1007/s00401-011-0933-9", "22212630"]}, {"Citation": "Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Cancer. (2006) 107:696\u2013704. 10.1002/cncr.22041", "ArticleIdList": ["10.1002/cncr.22041", "16826579"]}, {"Citation": "Cranmer LD, Trevor KT, Bandlamuri S, Hersh EM. Rodent models of brain metastasis in melanoma. Melanoma Res. (2005) 15:325\u201356. 10.1097/00008390-200510000-00002", "ArticleIdList": ["10.1097/00008390-200510000-00002", "16179861"]}, {"Citation": "Banks WA. Characteristics of compounds that cross the blood-brain barrier. BMC Neurol. (2009) 9:S3. 10.1186/1471-2377-9-S1-S3", "ArticleIdList": ["10.1186/1471-2377-9-S1-S3", "PMC2697631", "19534732"]}, {"Citation": "Wanat K. Biological barriers, and the influence of protein binding on the passage of drugs across them. Mol Biol Rep. (2020) 47:3221\u201331. 10.1007/s11033-020-05361-2", "ArticleIdList": ["10.1007/s11033-020-05361-2", "32140957"]}, {"Citation": "Lucignani G, Ottobrini L, Martelli C, Rescigno M, Clerici M. Molecular imaging of cell-mediated cancer immunotherapy. Trends Biotechnol. (2006) 24:410\u20138. 10.1016/j.tibtech.2006.07.003", "ArticleIdList": ["10.1016/j.tibtech.2006.07.003", "16870284"]}]}], "History": [{"Year": "2020", "Month": "3", "Day": "2"}, {"Year": "2020", "Month": "4", "Day": "29"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "6", "Day": "18", "Hour": "6", "Minute": "1"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32547952", "PMC7269144", "10.3389/fonc.2020.00854"]}}]}